Funds holding TRINITY BIOTECH PLC
ISIN US8964385046 · Ireland · LEI 635400ESQQYRIISTLB94
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 12K $
A single tracked fund declares this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 16,642 | 12K $ | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 16,642 | 0.0 % |
| 2026Q1 | 1 | 0 | 16,642 | 0.0 % |
| 2025Q4 | 1 | 0 | 16,642 | 0.0 % |
| 2025Q3 | 1 | 0 | 16,642 | -5.8 % |
| 2025Q2 | 1 | 0 | 17,675 | +248.1 % |
| 2025Q1 | 1 | 0 | 5,077 | 0.0 % |
| 2024Q4 | 1 | 0 | 5,077 | +391.5 % |
| 2024Q3 | 1 | 0 | 1,033 | 0.0 % |
| 2024Q2 | 1 | 1,033 |
Institutional managers
23 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 536,210 | 292 $ | as of Mar 31, 2026 |
| Yorkville Advisors Global, LP | 225,000 | 122K $ | as of Mar 31, 2026 |
| Williams & Novak, LLC | 107,643 | 64.4K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 26,676 | 14 $ | as of Mar 31, 2026 |
| Moss Adams Wealth Advisors LLC | 25,666 | 13.9K $ | as of Mar 31, 2026 |
| INSPIRION WEALTH ADVISORS, LLC | 25,000 | 13.6K $ | as of Mar 31, 2026 |
| Cambridge Investment Research Advisors, Inc. | 22,280 | 12 $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 20,319 | 11K $ | as of Mar 31, 2026 |
| BECKER CAPITAL MANAGEMENT INC | 18,000 | 9.8K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 17,762 | 9.6K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 16,642 | 9K $ | as of Mar 31, 2026 |
| LPL Financial LLC | 15,036 | 8.2K $ | as of Mar 31, 2026 |
| RHUMBLINE ADVISERS | 5,547 | 3K $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 3,804 | 2.3K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 2,500 | 1.4K $ | as of Mar 31, 2026 |
| Farther Finance Advisors, LLC | 2,000 | 1.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 1,007 | 546 $ | as of Mar 31, 2026 |
| Triumph Capital Management | 1,000 | 542 $ | as of Mar 31, 2026 |
| SIMPLEX TRADING, LLC | 555 | 300 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 402 | 218 $ | as of Mar 31, 2026 |
| ATWOOD & PALMER INC | 20 | 11 $ | as of Mar 31, 2026 |
| McIlrath & Eck, LLC | 5 | 3 $ | as of Mar 31, 2026 |
| CoreCap Advisors, LLC | 1 | 1 $ | as of Mar 31, 2026 |
Declared shareholders of TRINITY BIOTECH PLC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Perceptive Advisors LLC and 4 others | 9.90 % | 3,424,019,957 | as of Apr 30, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding TRINITY BIOTECH PLC". https://titelia.com/en/stocks/trinity-biotech-plc-US8964385046